|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02367 GIANT BIOGENE
Nominal 
51.350 -0.400 (-0.773%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 35.796% | 18.191% | 15.730% | 37.160% | 30.733% |
| ROAE (%) | 40.351% | 52.049% | 112.303% | 102.939% | 48.119% |
| Return on Capital Employed (%) | 32.679% | 35.069% | 80.000% | 173.181% | 47.166% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 83.627% | 84.385% | 87.237% | 84.594% | 83.277% |
| EBITDA Margin (%) | 49.143% | 50.424% | 63.622% | 82.794% | 70.941% |
| Pre-tax Profit Margin (%) | 49.518% | 49.811% | 62.668% | 81.752% | 70.764% |
| Net Profit Margin (%) | 41.194% | 42.379% | 53.342% | 69.422% | 57.725% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 7.793 X | 9.034 X | 1.087 X | 1.051 X | 2.329 X |
| Quick Ratio (X) | 7.415 X | 8.379 X | 1.074 X | 1.021 X | 2.248 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 12.106% | 9.598% | 87.093% | 82.724% | 35.922% |
| Total Debt / Total Assets (%) | 0.055% | 0.082% | 0% | 0% | 0% |
| Net Debt / Total Assets (%) | -50.296% | -42.329% | -90.160% | -13.874% | -4.025% |
| Total Debt / Shareholders' Funds (%) | 0.063% | 0.091% | 0% | 0% | 0% |
| Long Term Debt / Shareholders' Funds (%) | 0.027% | 0.060% | 0% | 0% | 0% |
| Net Debt / Shareholders' Funds (%) | -57.340% | -46.881% | -698.557% | -80.306% | -6.302% |
| Net Cash / (Debt) ($) | 2.501B | 1.328B | 7.103B | 367.805M | 72.323M |
| Net Cash / (Debt) per share ($) | 2.514 | 1.335 | -- | -- | -- |
| Total Debt / Capital Employed (%) | 0.061% | 0.091% | 0% | 0% | 0% |
| Interest Coverage Ratio (X) | 15582.152 X | 56084.286 X | -- | -- | -- |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 121.560 Day | 135.088 Day | 141.884 Day | 114.946 Day | 116.038 Day |
| Receivables Turnover (Day) | 8.879 Day | 10.425 Day | 14.125 Day | 11.004 Day | 6.585 Day |
| Payables Turnover (Day) | 9.723 Day | 6.041 Day | 6.531 Day | 8.389 Day | 8.691 Day |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 983,164 |
| %Change | 47.414% |
| EPS / (LPS) | RMB 0.990 |
| NBV Per Share (¥) | RMB 5.806 |